112 related articles for article (PubMed ID: 15174726)
21. Choroidal involvement in lymphomatoid granulomatosis.
Pearson AD; Craft AW; Howe JM
Br J Ophthalmol; 1991 Nov; 75(11):688-9. PubMed ID: 1751466
[TBL] [Abstract][Full Text] [Related]
22. [Alternating chemotherapy with cyclophosphamide, adriamycin, vincristine and prednisolone (CHOP); etoposide, procarbazine, vindesine and prednisolone (EPVP) as a treatment for advanced-stage Hodgkin's disease].
Kumagai K; Takagi T; Sakai C; Wakatsuki S
Gan To Kagaku Ryoho; 1996 Mar; 23(4):499-501. PubMed ID: 8678506
[No Abstract] [Full Text] [Related]
23. Angiocentric lymphomatoid granulomatosis and severe hypogammaglobulinaemia.
Váróczy L; Gergely L; Szakáll S; Illés A
Haematologia (Budap); 2002; 32(4):535-41. PubMed ID: 12803130
[TBL] [Abstract][Full Text] [Related]
24. Severe skin necrosis after rituximab-CHOP therapy.
Botden IP; Leys MB; van Houten AA; Peeters RP
Neth J Med; 2008 Nov; 66(10):448-9. PubMed ID: 19011274
[No Abstract] [Full Text] [Related]
25. A randomized comparative study of cyclophosphamide, vincristine, doxorubicin, and prednisolone and cyclophosphamide, vincristine, mitoxantrone, and prednisolone regimens in the treatment of intermediate- and high-grade lymphoma with 8 years' follow-up.
Bezwoda WR; Rastogi RB
Semin Hematol; 1994 Apr; 31(2 Suppl 3):3. PubMed ID: 8073304
[No Abstract] [Full Text] [Related]
26. R-CHOP followed by consolidative autologous stem cell transplant and low dose rituxan maintenance therapy for advanced mantle cell lymphoma.
Lim SH; Esler WV; Periman PO; Beggs D; Zhang Y; Townsend M
Br J Haematol; 2008 Jul; 142(3):482-4. PubMed ID: 18510683
[No Abstract] [Full Text] [Related]
27. Sezary syndrome.
Ali CM; Sikdar TK; Sultana N; Hoque MR; Ahmed N; Parvez Z; Kamal B; Rahman F
Mymensingh Med J; 2011 Jul; 20(3):497-500. PubMed ID: 21804519
[TBL] [Abstract][Full Text] [Related]
28. Rituximab and CHOP induction therapy for newly diagnosed mantle-cell lymphoma: molecular complete responses are not predictive of progression-free survival.
Howard OM; Gribben JG; Neuberg DS; Grossbard M; Poor C; Janicek MJ; Shipp MA
J Clin Oncol; 2002 Mar; 20(5):1288-94. PubMed ID: 11870171
[TBL] [Abstract][Full Text] [Related]
29. A case of oral mycosis fungoides successfully treated by combination of alemtuzumab and chemotherapy.
Postorino M; Pupo L; Provenzano I; Del Principe MI; Buccisano F; Franceschini L; Rizzo M; Nasso D; Meconi F; Onnis I; Vaccarini S; Zizzari A; Anemona L; Mauramati S; Bruno E; Cantonetti M; Amadori S
Ann Hematol; 2016 Jan; 95(1):153-154. PubMed ID: 26442854
[No Abstract] [Full Text] [Related]
30. Lymphomatoid Granulomatosis with Isolated Cutaneous Lesions: Prolonged Remission After DA-EPOCH Protocol.
Gupta VG; Gogia A; Sharma V; Mallick S
Turk J Haematol; 2018 Aug; 35(3):213-214. PubMed ID: 29856361
[No Abstract] [Full Text] [Related]
31. Unusual case of lymphoma.
Lin M; Saunders CA; Ho Shon IA; Estell J; Howlin K; Lee V; Lin P
Intern Med J; 2006 Jul; 36(7):468-9. PubMed ID: 16780457
[No Abstract] [Full Text] [Related]
32. Reduced neurotoxicity with combined treatment of high-dose methotrexate, cyclophosphamide, doxorubicin, vincristine and prednisolone (M-CHOP) and deferred radiotherapy for primary central nervous system lymphoma.
Ichikawa T; Kurozumi K; Michiue H; Ishida J; Maeda Y; Kondo E; Kawasaki A; Date I
Clin Neurol Neurosurg; 2014 Dec; 127():106-11. PubMed ID: 25459253
[TBL] [Abstract][Full Text] [Related]
33. Anemia and erythropoiesis-stimulating agent administration in patients with non-Hodgkin lymphoma treated with cyclophosphamide, doxorubicin, vincristine, and prednisolone ± rituximab chemotherapy: results from an observational study.
Haioun C; Salar A; Pettengell R; Johnsen HE; Duehrsen U; Rossi FG; Verhoef G; Schwenkglenks M; Jaeger U; Hamilton L; Pujol B; Lugtenburg PJ
Leuk Lymphoma; 2011 May; 52(5):796-803. PubMed ID: 21338278
[TBL] [Abstract][Full Text] [Related]
34. Radiotherapy to control CNS lymphomatoid granulomatosis: a case report and review of the literature.
Petrella TM; Walker IR; Jones GW; Leber B
Am J Hematol; 1999 Dec; 62(4):239-41. PubMed ID: 10589080
[TBL] [Abstract][Full Text] [Related]
35. A prospective study of reduced-dose three-course CHOP followed by involved-field radiotherapy for patients 70 years old or more with localized aggressive non-Hodgkin's lymphoma.
Shikama N; Oguchi M; Isobe K; Nakamura K; Tamaki Y; Hasegawa M; Kodaira T; Sasaki S; Kagami Y;
Int J Radiat Oncol Biol Phys; 2006 Sep; 66(1):217-22. PubMed ID: 16814951
[TBL] [Abstract][Full Text] [Related]
36. [Multiple excavated pulmonary opacities].
Hommadi A; Ouarssani A; Ziadi T; Rguibi M; Drissi SM
Rev Med Interne; 2009 Apr; 30(4):351-2. PubMed ID: 18572279
[No Abstract] [Full Text] [Related]
37. New treatment strategies for aggressive lymphoma.
Younes A
Semin Oncol; 2004 Dec; 31(6 Suppl 15):10-3. PubMed ID: 15726533
[TBL] [Abstract][Full Text] [Related]
38. Plasmablastic lymphoma: successful management with CHOP and lenalidomide in resource constraint settings.
Yanamandra U; Sahu KK; Jain N; Prakash G; Saikia U; Malhotra P
Ann Hematol; 2016 Oct; 95(10):1715-7. PubMed ID: 27324386
[No Abstract] [Full Text] [Related]
39. Successful management with CHOP for pulmonary lymphomatoid granulomatosis in a dog.
Hatoya S; Kumagai D; Takeda S; Yamamoto E; Nakanishi M; Kuwamura M; Sugiura K; Sasai H; Yamate J; Inaba T
J Vet Med Sci; 2011 Apr; 73(4):527-30. PubMed ID: 21139353
[TBL] [Abstract][Full Text] [Related]
40. [Treatment of elderly patients with non-Hodgkin's lymphoma].
Titorenko IB; Kriachok IA
Lik Sprava; 2011; (5-6):79-85. PubMed ID: 22606896
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
